Your email has been successfully added to our mailing list.

×
4.28559184022924E-05 -8.57118368047066E-05 -8.57118368047066E-05 0 4.28559184022924E-05 -8.57118368047066E-05 -0.000171423673609291 -8.57118368047066E-05
Stock impact report

Can We End Cancer? | Healthcare Summit 2018 [Forbes]

LOXO ONCOLOGY (LOXO) 
Last loxo oncology earnings: 11/8 06:45 am Check Earnings Report
US:NASDAQ Investor Relations: ir.loxooncology.com
Company Research Source: Forbes
Can We End Cancer? | Healthcare Summit 2018 Jan 18, 2019 @ 01:20 PM Can We End Cancer? | Summit 2018 Presented By Breakthroughs in immunotherapy and genetics are leading to amazingly effective cancer drugs. How far can this research take us? Joshua H. Bilenker, M.D., President & Chief Executive Officer, Loxo Oncology, David Chang, M.D., Ph.D., President, Chief E Show less Read more
Impact Snapshot
Event Time:
LOXO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for LOXO alerts
Opt-in for
LOXO alerts

from News Quantified
Opt-in for
LOXO alerts

from News Quantified